Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
75.54 USD | -3.13% | +3.34% | +143.76% |
07-10 | Goldman Sachs Raises Price Target on Insmed to $102 From $74, Maintains Buy Rating | MT |
07-09 | Guggenheim Adjusts Price Target on Insmed to $95 From $70, Maintains Buy Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+143.76% | 12.18B | |
+20.03% | 126B | |
+23.61% | 117B | |
+22.71% | 27.52B | |
-18.07% | 20.87B | |
-15.43% | 17.01B | |
-14.81% | 16.26B | |
+9.78% | 14.56B | |
-46.10% | 15.09B | |
+52.34% | 13.89B |
- Stock Market
- Equities
- INSM Stock
- News Insmed Incorporated
- Transcript : Insmed Incorporated Presents at 39th Annual JPMorgan Virtual Healthcare Conference, Jan-12-2021 04